Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pixaby

Moderna To establish New Vaccine Facility In Britain

Moderna Inc (NASDAQ:MRNA) announced an agreement with the United Kingdom government to establish an mRNA Innovation and Technology Center in the U.K. Additionally, Moderna plans to expand its presence in the U.K. through investments in R&D activities. Moderna is collaborating with the National Institute for Health Research on a Phase 3 study…

Moderna's COVID-19 Shot Likely Related To Higher Heart Inflammation Risk Than Pfizer's: Reuters

Moderna's COVID-19 Shot Likely Related To Higher Heart Inflammation Risk Than Pfizer's: Reuters

Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccine may relate to a higher risk of heart inflammation in some age groups than Pfizer Inc (NYSE:PFE) - BioNTech SE's (NASDAQ:BNTX) shot, Reuters reported citing the Centers for Disease Control and Prevention. Citing recent data, CDC said that the findings on myocarditis and pericarditis, types of heart inflammation linked to both the…

Germany's Allianz Sets Aside Additional $2B For Fund Fiasco: Reuters

Germany's Allianz Sets Aside Additional $2B For Fund Fiasco: Reuters

Allianz SE (OTC:ALIZY) said it would set aside another €1.9 billion ($2 billion) as it braces for the outcome of U.S. regulatory investigations into a multibillion-dollar trading debacle at its fund's arm. The collapse of a $15 billion set of investment funds during the pandemic market turmoil in early 2020 has cast a…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Walgreens Announces $683M Opioid Settlement With Florida

Walgreens Boots Alliance Inc (NASDAQ:WBA) has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state. The settlement includes $620 million to be paid to Florida over 18 years, plus $63 million for legal fees. The settlement ends a trial that began…

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters

Moderna Inc's (NASDAQ:MRNA) chief medical officer said that its COVID-19 vaccine for children under six years old would be ready for review by the FDA panel when it meets in June. "I think the FDA now has all of the core fundamental data they need to be able to begin an application review.…

Russia Punishes Meta For Alleged LGBT Propaganda

A Russian court penalized Meta Platforms Inc (NASDAQ:FB) 4 million roubles ($0.05 million) for allegedly failing to delete posts that contain "LGBT propaganda," Reuters reports. A 2013 Russian law bans the "promotion of non-traditional sexual relations to minors." Previously, Russia slapped a criminal case against the Facebook parent for allowing users to call for "death…

inkl

Read news from The Economist, FT, and more,
with one subscription

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

Goldman Sachs Reported Morgan Stanley Bulk Share Sales To Hong Kong Regulator: FT

Goldman Sachs Reported Morgan Stanley Bulk Share Sales To Hong Kong Regulator: FT

Goldman Sachs Group Inc (NYSE:GS) reported bank Morgan Stanley (NYSE:MS) to Hong Kong’s financial regulator over a series of block trades, Financial Times reported citing people familiar with the matter. As part of an “informal” discussion, Goldman alerted the territory’s Securities and Futures Commission three years ago about share price drops in a few Hong…

Moderna Says Dual Variant COVID-19 Booster With Beta is Better Effective Against Omicron Than Current Jab

Moderna Says Dual Variant COVID-19 Booster With Beta is Better Effective Against Omicron Than Current Jab

Moderna Inc (NASDAQ:MRNA) said a COVID-19 booster designed to target the Beta variant and the original coronavirus generated a better immune response against several virus variants, including Omicron. Moderna said the results were a good sign for the company's plans for future shots targeting two COVID-19 variants. The company said the bivalent…

Two long COVID Patients Recover After Pfizer's Therapy; Side Effects, Safety Needs To Be Assessed: Reuters

Two long COVID Patients Recover After Pfizer's Therapy; Side Effects, Safety Needs To Be Assessed: Reuters

Reuters reported that two patients found relief from long COVID after taking Pfizer Inc's (NYSE:PFE) antiviral Paxlovid, including a researcher who tested it on herself. Long COVID is estimated to affect up to 30% of people infected with the coronavirus. It can last for months. More than 200 symptoms have been associated with the…

Britain Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Britain Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Britain's medicines regulator approved the use of Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccine in children between six and 11 years. The Medicines and Healthcare products Regulatory Agency (MHRA) said the approval was granted after Moderna's vaccine, known as Spikevax, met the required safety, quality, and effectiveness standards. Read Next: Why Did Moderna Recall Thousands Of COVID-19…

Why Did Moderna Recall Thousands Of COVID-19 Vaccine Doses In Europe?

Why Did Moderna Recall Thousands Of COVID-19 Vaccine Doses In Europe?

Moderna Inc (NASDAQ:MRNA) recalled 764,900 doses of its COVID-19 vaccine made by its Spanish contract manufacturer Rovi after a foreign body contaminated a vial. No safety issues have been identified, Moderna said, about the lots distributed in Norway, Poland, Portugal, Spain, and Sweden in January. Japanese authorities last year suspended the use of…

Pfizer/BioNTech's COVID- Vaccine Cuts Hospitalization Risk In Kids Aged 5-11 Years: Reuters

Pfizer/BioNTech's COVID- Vaccine Cuts Hospitalization Risk In Kids Aged 5-11 Years: Reuters

According to a US-based study, children ages 5 to 11 who received the Pfizer Inc (NYSE:PFE) / BioNTech SE's (NASDAQ:BNTX) COVID-19 vaccine were 68% less likely to be hospitalized during the omicron wave than unvaccinated children. Adolescents aged 12-18 who received two shots of the vaccine were around 40% less likely to be hospitalized with the…

Get all your
news in one place.

100's of premium titles.
One news app.

Goldman Sachs Pauses Relations With Sanctioned Oligarch Linked PE Firm: FT

Goldman Sachs Group (NYSE:GS) and Kirkland & Ellis halted new business with Pamplona Capital Management, the Financial Times reports. Sanctioned oligarch Mikhail Fridman's LetterOne investment group accounted for 80% of the funds of the $9 billion private equity firm. Waystone, a Cayman Islands firm, resigned from every role with Pamplona funds on…

Moderna's COVID-19 Vaccine Shows Neutralizing Antibody Response In Kids Under 6

Moderna Inc (NASDAQ:MRNA) has announced interim data from the Phase 2/3 KidCOVE study of its COVID-19 vaccine (mRNA-1273) in children six months to under six years. The interim analysis showed that two 25 μg doses of mRNA-1273 in participants 6 months to under six years met the primary endpoint with robust neutralizing antibody…

Health Canada Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Health Canada has approved Moderna Inc's (NASDAQ:MRNA) mRNA COVID-19 vaccine, Spikevax, two-dose series of 50 µg per dose to prevent COVID-19 in children aged six to11 years. The announcement follows the recent authorization of the Company's COVID-19 vaccine in the same age group in both Australia and the European Union. "Health Canada was…

Apple iPhones Led Smartphone Sales As 5G Handsets Formed Over 50% Of Sales

Apple Inc’s (NASDAQ:AAPL) iPhones led the mobile industry to a landmark in January, as handsets with 5G cellular networking accounted for 51% of smartphone sales for the first time, Bloomberg reports. Recently, Apple launched a 5G model in its budget-friendly iPhone SE series, at half its average flagship device priced at $429. Chinese brands Xiaomi…

Get all your
news in one place.

100's of premium titles.
One news app.

TSMC's Revenue From Leading Client Apple Sees Significant Rise

Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM) saw a radical climb in the revenue from its leading customer, DigiTimes reports. Revenue from TSMC's biggest client Apple Inc (NASDAQ:AAPL), will likely jump by 20% year-on-year to NT$405.4 billion ($14.3 billion) in 2021. Apple's revenue jump could form ~26% of the foundry's total wafer revenue for the…

Moderna Plans Vaccines Against 15 Pathogens With Future Pandemic Potential

Moderna Inc (NASDAQ: MRNA) plans to develop and begin testing vaccines targeting 15 pathogens identified as the biggest public health risk by WHO and CEPI by 2025. The Company also said it would permanently wave its COVID-19 vaccine patents for shots intended for certain low- and middle-income countries. At its global public health strategy,…

Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales

Moderna Inc (NASDAQ:MRNA) reports a Q4 EPS of $11.29, a turnaround from an EPS loss of $(0.69) a year ago, beating the consensus estimate of $9.90. The Company clocked Q4 revenues of $7.21 billion compared to just $571 million a year ago, beating the consensus of $6.79 billion. Product sales were $6.9…

Call of Duty's Planned 2023 Release Delayed By Activision: Bloomberg

Activision Blizzard Inc (NASDAQ:ATVI) looks to delay a "Call of Duty" (COD) game, Bloomberg reports. The failure of recent COD releases to meet sales expectations triggered the belief that Activision introduced new versions too rapidly. Activision initially aimed to release the game in 2023. The postponement will make 2023 the first year…

1

People

Mikhail Fridman

Stephane Bancel

Stéphane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

359,075 stories

135,704 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play